Combined positronemission tomography and computed tomography (PET/CT) imaging in staging esophageal cancer - analysis of 12 cses
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 8
Abstract
Positron emission tomography (PET) with the use of fluoride-18-fluorodeoxyglucose (FDG) has become more and more popular in the diagnosis and treatment of neoplasms. When FDG-PET is combined with computed tomography (CT), diagnostic possibilities increase. The aim of this study was to retrospectively assess the clinical value of PET/CT fusion images, considering esophageal carcinoma staging. PET/CT images of the whole body were performed in 12 male patients, aged between 36 and 78 years (mean age: 59.1 years). Increased glucose utilization foci (FDG uptake) were noted in all patients. Increased focal FDG uptake beyond the limits of the esophagus was observed in the case of six patients, including two in the lungs, and five in the mediastinal, supraclavicular, cervical, epigastric and supraclavicular space lymph nodes. In the case of three patients subject to therapeutic resection procedures, two neoplastic lesion diagnoses observed during PET/CT examinations were confirmed by means of intraoperative and postoperative histopathological examinations. In the case of the third patient, the diagnosis proved falsely negative, considering regional lymph nodes metastases. In four cases, the PET/CT examination was insufficient, considering the depth of esophageal wall infiltration and/or presence of regional lymph nodes metastases. Based on the PET/CT examination, five patients were diagnosed with stage IV esophageal carcinoma. In the case of three patients, the PET/CT examination result leads towards upstaging. The PET/CT examination is of great value in the determination of the clinical stage of esophageal carcinoma. The use of PET/CT increases the efficacy of distant lymph nodes and internal organ metastases diagnosis. In selected patients, the above-mentioned examination, changes the staging of esophageal carcinoma, and thus, therapeutic options. When evaluating the depth of esophageal wall and mediastinal lymph nodes infiltration, the PET/CT examination is probably of lesser clinical value. Considering patients qualified towards surgical intervention, the evaluation of the stage of esophageal cancer by means of the PET/CT examination might bring about measurable benefits.
Authors and Affiliations
Zbigniew Kula, Tomasz Pietrzak, Katarzyna Kobus - Błachnio, Zdzisław Zuchora
Quality of life in stoma patients
Saving the lives of a greater and greater number of elderly and often unhealthy and disabled patients has become a great achievement of modern medicine. On the other hand it has created the challenge of making those live...
\"Novus ordo seclorum\": new applications af monoclonal antibodies in breast cancer
Trastuzumab (Herceptin) is a recombinant humanized monoclonal IgG1 antibody inhibiting selectively HER2 receptor in tumour cells, that has found a clinical application in breast cancer treatment. Until recently, this com...
Przeszczepianie komórek krwiotwórczych od dawców allogenicznych: wyniki leczenia na podstawie doświadczenia Dolnośląskiego Centrum Transplantacji Komórkowych z Krajowym Bankiem Dawców Szpiku
Przeszczepianie macierzystych komórek krwiotwórczych (HSCT) od allogenicznego dawcy jest postępowaniem z wyboru w leczeniu części chorych z ciężkimi niedoborami tkanki krwiotwórczej i nowotworami tego układu. Analiza k...
Sprawozdanie z 17th International Symposium Supportive Care in Cancer
Analiza czynników prognostycznych u chorych na raka wpustu leczonych operacyjnie
Cel pracy: Analiza przeżyć chorych z rakiem wpustu w zależności od czynników związanych z biologią nowotworu oraz czynników zależnych od chirurga. Materiał i metody: W latach 1988–2000, u 59 chorych wykonano całkowitą r...